Chemomab Therapeutics Ltd.

CMMB ·Healthcare, Drug Manufacturers - General
Financial Statements › SEC Filings

SEC Filings

Form Filed Description
6-K Apr 15, 2025 6-K
SCHEDULE 13G/A Apr 10, 2025
20-F Apr 4, 2025 20-F
6-K Mar 27, 2025 6-K
6-K Mar 20, 2025 6-K
6-K Mar 3, 2025 6-K
6-K Feb 19, 2025 6-K
EFFECT Dec 10, 2024
POS AM Dec 2, 2024 POS AM
SC 13D/A Nov 29, 2024 SC 13D/A
SC 13G Nov 21, 2024 SCHEDULE 13G
6-K Nov 18, 2024 6-K
424B5 Nov 15, 2024 424B5
6-K Nov 14, 2024 6-K
6-K Oct 11, 2024 6-K
SC 13D/A Sep 16, 2024 AMENDMENT NO. 4
144 Sep 12, 2024
424B3 Sep 9, 2024 424B3
EFFECT Sep 6, 2024
CORRESP Sep 4, 2024
UPLOAD Aug 29, 2024
F-3 Aug 23, 2024 F-3
6-K Aug 21, 2024 6-K
SC 13G Aug 20, 2024 SC 13G
D Aug 9, 2024
← Newer Page 3 of 15 · 369 filings Older →